ESTEVE Strengthens US Presence by Acquiring TerSera's Injectable Specialty Drugs Division ESTEVE has completed the acquisition of TerSera Therapeutics' specialty injectable unit, enhancing its capabilities in the US pharmaceutical market.

ESTEVE Strengthens US Presence by Acquiring TerSera's Injectable Specialty Drugs Division #USA #Deerfield #ESTEVE #TerSera #Quzyttir

ESTEVE Expands US Presence by Acquiring Infusion Specialty Therapies from TerSera Therapeutics ESTEVE has announced its acquisition of TerSera Therapeutics' Infusion Specialty Therapies division, enhancing its US market presence with specialized products.

ESTEVE Expands US Presence by Acquiring Infusion Specialty Therapies from TerSera Therapeutics #USA #Deerfield #ESTEVE #TerSera #Infusion_Therapies

ESTEVE to Expand U.S. Presence by Acquiring TerSera Therapeutics' Infusion Therapy Business The acquisition of TerSera Therapeutics' infusion therapy business allows ESTEVE to broaden its reach within the highly specialized pharmaceuticals market in the U.S.

ESTEVE to Expand U.S. Presence by Acquiring TerSera Therapeutics' Infusion Therapy Business #USA #Deerfield #ESTEVE #TerSera #InfusionTherapy

ESTEVE Expands U.S. Market Footprint with TerSera Therapeutics Acquisition ESTEVE announces its acquisition of TerSera Therapeutics' Infusion Specialty Therapies Business Unit, enhancing its offerings in the U.S. market.

ESTEVE Expands U.S. Market Footprint with TerSera Therapeutics Acquisition #USA #pharmaceuticals #Deerfield #ESTEVE #TerSera